LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Biogen Inc. Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$1.93M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
+30.92%
quarter
Biogen Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.36% | -26 shares | 452K | $267 | 7.25K |
| Q2 2022 | share | Increase | +0.36% | 26 shares | -43K | $203.94 | 7.28K |
| Q1 2022 | share | 0.00% | 0 shares | -213K | $210.6 | 7.25K | |
| Q4 2021 | share | Decrease | -5.22% | -400 shares | -425K | $240 | 7.25K |
| Q3 2021 | share | Decrease | -0.97% | -75 shares | -511K | $282.99 | 7.65K |
| Q2 2021 | share | Decrease | -5.71% | -468 shares | 383K | $346.27 | 7.73K |
| Q1 2021 | share | Decrease | -1.04% | -86 shares | 266K | $279.75 | 8.20K |
| Q4 2020 | share | Increase | +0.05% | 4 shares | -321K | $244.86 | 8.28K |
| Q3 2020 | share | 0.00% | 0 shares | 134K | $283.68 | 8.28K | |
| Q2 2020 | share | 0.00% | 0 shares | -405K | $267.55 | 8.28K | |
| Q1 2020 | share | 0.00% | 0 shares | 163K | $316.38 | 8.28K | |
| Q4 2019 | share | Decrease | -0.13% | -11 shares | 527K | $296.73 | 8.28K |
| Q3 2019 | share | Decrease | -0.60% | -50 shares | -21K | $232.82 | 8.29K |
| Q2 2019 | share | Decrease | -0.33% | -28 shares | -27K | $233.87 | 8.34K |
| Q1 2019 | share | Decrease | -0.64% | -54 shares | -557K | $236.38 | 8.37K |
| Q4 2018 | share | Increase | +0.64% | 54 shares | -422K | $300.92 | 8.42K |
| Q3 2018 | share | Decrease | -1.18% | -100 shares | 499K | $353.31 | 8.37K |
| Q2 2018 | share | 0.00% | 0 shares | 139K | $290.24 | 8.47K | |
| Q1 2018 | share | Decrease | -0.59% | -50 shares | -395K | $273.82 | 8.47K |
| Q4 2017 | share | 0.00% | 0 shares | 46K | $318.57 | 8.52K | |
| Q3 2017 | share | Increase | +0.13% | 11 shares | 204K | $313.12 | 8.52K |
| Q2 2017 | share | Increase | +0.33% | 28 shares | 145K | $271.36 | 8.51K |
| Q1 2017 | share | Increase | +8.99% | 700 shares | 113K | $273.42 | 8.48K |
| Q4 2016 | share | 0.00% | 0 shares | -230K | $283.58 | 7.78K | |
| Q3 2016 | share | Increase | +0.65% | 50 shares | 567K | $313.03 | 7.78K |
| Q2 2016 | share | 0.00% | 0 shares | -143K | $241.82 | 7.73K | |
| Q1 2016 | share | Decrease | -0.26% | -20 shares | -362K | $260.32 | 7.73K |